These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2509074)

  • 21. [A study on the effectiveness of hepatitis B vaccine among the vaccinated population].
    Wang C; Li D
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):43-6. PubMed ID: 10322708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-benefit analysis of hepatitis a vaccination in Thailand.
    Teppakdee A; Tangwitoon A; Khemasuwan D; Tangdhanakanond K; Suramaethakul N; Sriratanaban J; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):118-27. PubMed ID: 12118439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis.
    Mulley AG; Silverstein MD; Dienstag JL
    N Engl J Med; 1982 Sep; 307(11):644-52. PubMed ID: 6810170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cost-benefit analysis of vaccinal prevention of hepatitis B policy].
    Kerleau M; Flori YA; Nalpas B; Lanoé JL; Berthelot P; Fardeau-Gautier M
    Rev Epidemiol Sante Publique; 1995; 43(1):48-60. PubMed ID: 7892516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen].
    Liu KZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):132-4. PubMed ID: 2582918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B vaccine: clinical experience.
    Tron F
    IARC Sci Publ; 1984; (63):279-95. PubMed ID: 6242147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal hepatitis B vaccination: the economics of prevention.
    Krahn MD; Detsky AS
    CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-benefit analysis of hepatitis B vaccination.
    Jönsson B
    Postgrad Med J; 1987; 63 Suppl 2():27-32. PubMed ID: 3120169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou].
    Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen.
    Schalm SW; Mazel JA; de Gast GC; Heijtink RA; Botman MJ; Bänffer JR; Cerards LJ; Zwijnenberg J; Fetter WP; Nuijten SM
    Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing].
    Gong XH; Wang FZ; Li H; Liu LR; Li YH; Wang BL; Li LQ; Zhang Z; Han QY; Tang YW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Jul; 39(4):265-8. PubMed ID: 16194384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
    Plans-Rubió P
    Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of hepatitis A and hepatitis B by vaccination].
    Buisson Y; Meyran M
    Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.